Hepatorenal syndrome

Samir Mohindra, Kundan Kumar
{"title":"Hepatorenal syndrome","authors":"Samir Mohindra,&nbsp;Kundan Kumar","doi":"10.1016/j.cqn.2013.11.002","DOIUrl":null,"url":null,"abstract":"<div><p><span>Renal dysfunction is commonly seen in patients with </span>end stage liver disease<span>. Prognosis of patients who develop hepatorenal syndrome<span> (HRS) is dismal with a median survival of around six months without liver transplantation<span>. Advances in understanding of the pathophysiology of HRS has lead to evolving ideas regarding the definition and diagnostic criteria of HRS. In addition, recent pharmacological and other therapeutic innovations provide hope to patients of HRS. This is a review of diagnostic criteria, etio-pathogenesis and therapeutic options for patients of HRS based on the available evidence in literature.</span></span></span></p></div>","PeriodicalId":100275,"journal":{"name":"Clinical Queries: Nephrology","volume":"2 4","pages":"Pages 205-211"},"PeriodicalIF":0.0000,"publicationDate":"2013-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cqn.2013.11.002","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Queries: Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221194771300037X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Renal dysfunction is commonly seen in patients with end stage liver disease. Prognosis of patients who develop hepatorenal syndrome (HRS) is dismal with a median survival of around six months without liver transplantation. Advances in understanding of the pathophysiology of HRS has lead to evolving ideas regarding the definition and diagnostic criteria of HRS. In addition, recent pharmacological and other therapeutic innovations provide hope to patients of HRS. This is a review of diagnostic criteria, etio-pathogenesis and therapeutic options for patients of HRS based on the available evidence in literature.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Hepatorenal综合症
肾功能不全常见于终末期肝病患者。发生肝肾综合征(HRS)的患者预后不佳,不进行肝移植的中位生存期约为6个月。随着对HRS病理生理学认识的不断深入,对HRS的定义和诊断标准也有了新的认识。此外,最近的药理学和其他治疗创新为HRS患者提供了希望。本文将根据文献中现有的证据,对HRS的诊断标准、病因发病机制和治疗方案进行综述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Distal renal tubular acidosis with hypokalemic paralysis as primary presentation of Sjogren's syndrome without sicca symptoms: An unusual case presentation Tubular ectasia of rete testis – A diagnostic dilemma Duplex Doppler ultrasound for detection of significant renal artery stenosis in transplant kidney with end to side arterial anastomosis A rare cause of low back pain: A report of presacral schwannoma Imaging of forgotten indwelling D.J. stent with encrustment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1